Published in
Wiley, American Journal of Hematology, 4(97), p. 481-490, 2022
DOI: 10.1002/ajh.26480
Links
Tools
Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial
Journal article published in 2022 by
Evangelos Terpos 
,
Meletios A. Dimopoulos ,
Mario Boccadoro,
Sosana Delimpasi ,
Meral Beksac,
Eirini Katodritou ,
Philippe Moreau ,
Alessandra Pompa,
Argiris Symeonidis ,
Jelena Bila,
Albert Oriol,
Maria‐Victoria Mateos,
Hermann Einsele,
Ioannis Orfanidis,
Katharine S. Gries
and other authors.
,
Meletios A. Dimopoulos ,
Mario Boccadoro,
Sosana Delimpasi ,
Meral Beksac,
Eirini Katodritou ,
Philippe Moreau ,
Alessandra Pompa,
Argiris Symeonidis ,
Jelena Bila,
Albert Oriol,
Maria‐Victoria Mateos,
Hermann Einsele,
Ioannis Orfanidis,
Katharine S. Gries
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 